Inventor
WENDY LUO
Inventor
US
Overview
Patents· 10 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07DHeterocyclic compounds31%
A61KPreparations for medical, dental or toiletry purposes8%
C07BGeneral methods of organic chemistry8%
C07CAcyclic or carbocyclic compounds8%
C07KPeptides8%
PatentTitleYear
12,331,024Substituted naphthyl P38alpha mitogen-activated protein kinase inhibitors202512,269,792Crystalline 5-(dimethylamino)-N-(4-(morpholinomethyl) phenyl)naphthalene-1-sulfonamide di-hydrochloride di-hydrate202511,976,049Substituted naphthyl p38alpha mitogen-activated protein kinase inhibitors202411,926,635P38a mitogen-activated protein kinase inhibitors202411,753,445Therapeutic peptides202311,555,020Substituted naphthyl p38a mitogen-activated protein kinase inhibitors202311,440,918p38a mitogen-activated protein kinase inhibitors202211,390,581Crystalline 5-(dimethylamino)-n-(4-(morpholinomethyl)phenyl)naphthalene-1-sulfonamide di-hydrochloride di-hydrate202211,332,497Therapeutic peptides202211,286,260P38a mitogen-activated protein kinase inhibitors2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to GEN1E LIFESCIENCES INC (8)· patent assignee history
2022–2023Patents assigned to COHBAR INC (2)· patent assignee history
2022–2025Based in US· patent location history
2025Patents assigned to GENIE LIFESCIENCES INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GEN1E LIFESCIENCES INC | 8 | 2022–2025 |
| COHBAR INC | 2 | 2022–2023 |
| GENIE LIFESCIENCES INC | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 10 | 2022–2025 |